Biochanin A possibly prevents endothelial dysfunction via a complex network structure with multiple targets and pathways, among which AKT1, TNF-α, NOS3, ICAM-1, and VCAM-1 may be the key targets, according to network pharmacological analysis results. This evidence concerns the gene VCAM1 and endothelial dysfunction.